Total Delivery Pharma (TDP) is a specialist pharmaceutical quality and compliance consultancy supporting pharma and biotech companies across the UK, EU and US.
Our services span GMP and GDP quality leadership, QP/RP/RPi batch certification, auditing, QMS design, regulatory affairs, and inspection-ready remediation; across early-phase IMPs, advanced therapy medicinal products, and commercial supply chains.
We work in highly regulated pharmaceutical environments where decisions must stand up to scrutiny, internally and externally. Our consultants hold active experience across MHRA, EMA, FDA and WHO-regulated markets, supporting clients from clinical-stage start-ups to global pharmaceutical organisations.
Our support scales with your business, from first-in-human to commercial launch.
ABOUT TDP
Pharmaceutical Quality & Compliance Consultants | TDP
THE TEAM
Meet the people behind TDP
TDP's team brings together experienced QPs, quality specialists, regulatory consultants and operational leaders, working as a seamless extension of your own team.
LEADERSHIP
Managing & Founding Director
Director of Sales & Business Development
Director of Operations
QUALITY
TDP EXPERT COLLECTIVE
Have a quality or compliance challenge?
Book a free 30-minute consultation. No obligation, just a focused conversation about your licences, inspections, QMS or supply chain.
HOW WE WORK
Our approach
Patient-Centred Quality
Patient safety, product quality and fitness for purpose sit at the centre of every decision we make
Practical, Compliant Solutions
We combine deep technical detail with practical, risk-based thinking so recommendations can be implemented in the real world.
Transparency & Long-term Value
We act with honesty, transparency and a clear focus on long-term value, not short-term fixes.
We Deliver, Not Just Advise
We help you deliver and embed change so inspections, licences and patients see the benefit.
Continuous Improvement
We look for marginal and step-change improvements in systems, behaviours and data, building solutions that get better over time.
OUR WORK
Journey highlights
RARE DISEASE | QP SERVICES | 2024
300+ hours of QP support to get a life-changing AAV therapy to patients on time
A critical staffing shortfall threatened on-time batch certification for a rare disease AAV product. TDP integrated with the client team, maintained a batch-per-month release cadence over three months, and ensured patients gained timely access to a potentially life-changing treatment, delivered on time and within budget.
GENE THERAPY | CLINICAL SUPPLY | 2024 - 2026
20 months of uninterrupted gene therapy supply to UK and EU clinical trials
Patients in live clinical trials for an orphaned disease condition depended on uninterrupted supply. TDP provided sustained QP/QA expertise across a complex US–UK–EU regulatory landscape, keeping supply continuous for the entire duration of the engagement; not a single disruption.
AUDITING | NHS TENDER | 2024
Full audit, supplier response and QP sign-off delivered in 15 calendar days for an NHS blood product tender
An urgent due diligence audit was required to meet a critical NHS supply tender deadline. TDP mobilised a specialist two-person team within seven days of contact, completed a four-day on-site audit, managed the supplier findings response, and delivered the final report, enabling the client to bid successfully.
INTERIM LEADERSHIP| GLOBAL AUDIT | 2024 - 2025AUDITING | NHS TENDER | 2024
Placed as Interim Global Director of Audit at a blue-chip pharmaceutical multinational
TDP's consultant stepped into a global audit director role, reviewing risk methodologies, conducting training audits integrating EU and US GMP standards per ISO 19011, and redesigning the company's global audit plan. The engagement specifically bridged a critical EU compliance knowledge gap within the client's US-based audit function.
REGULATORY COMPLIANCE| WDA REMEDIATION | 2025
MHRA inspection passed with zero outstanding findings after full WDA remediation
A UK pharmaceutical wholesaler required comprehensive remediation of their Wholesale Distribution Authorisation; including a full rewrite and reissuance of their SOP portfolio. TDP delivered the remediation programme end-to-end. The subsequent MHRA inspection concluded with no outstanding issues.
WHERE WE WORK
Remote first, on-site when it counts
TDP is remote-first by design, supporting clients worldwide.
Our team holds active experience across MHRA, EMA, FDA and WHO-regulated environments, supporting clients from clinical-stage start-ups to global blue-chip pharmaceutical businesses.
We work in your time zone to keep decisions moving and minimise travel cost and disruption, and join you on-site when it adds value, including audits, inspections and key workshops
Remote-first delivery
Speed, responsiveness and minimal travel cost. We work in your time zone from day one.
On-site support
Audits, MHRA and EMA inspections, and critical workshops where physical presence adds value.
Embedded resourcing
From single specialists to full interim quality teams, integrated directly into your organisation.
Global reach
Active experience across MHRA, EMA, FDA and WHO-regulated markets worldwide